Rene Gonzalez

Combined Nivolumab and Ipilimumab or Monotherapy in Previously Untreated Melanoma

J. Larkin, P. Rutkowski, R. Gonzalez, 2017 .

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7)

Antoni Ribas, Jill Fredrickson, Omid Hamid, 2014, Journal of Translational Medicine.

NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Brian R. Gastman, Kenneth K. Tanabe, Christopher K. Bichakjian, 2016 .

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.

Yu Shyr, Fei Ye, Donald Lawrence, 2012, The New England journal of medicine.

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

Dirk Schadendorf, Reinhard Dummer, Paolo A Ascierto, 2015, The New England journal of medicine.

Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma

Jon Richards, Michael B Atkins, M. Atkins, 2010, Clinical Cancer Research.

NCCN Guidelines Insights: Melanoma, Version 3.2016.

Merrick I Ross, Susan M Swetter, Brian Gastman, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

John Kirkwood, Eric Whitman, Lee Cranmer, 2011, Investigational New Drugs.

ABT-737 synergizes with Bortezomib to kill melanoma cells

Yuchun Luo, David A. Norris, R. Gonzalez, 2011, Biology Open.

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.

Wei Zhou, Dirk Schadendorf, Reinhard Dummer, 2015, The Lancet. Oncology.

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib.

Jeffrey Weber, Keith T Flaherty, Zeynep Eroglu, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.